PRIVILEGED AND CONFIDENTIAL — ATTORNEY-CLIENT PRIVILEGED / ATTORNEY WORK PRODUCT
MEMORANDUM
TO: James Prentice, Partner; Sandra Tung, Partner
FROM: Ryan Kowalski, Lead Associate; Megan Chu, Working Associate
DATE: April 14, 2025
RE: Material Contracts Review — Luminex Systems Holdings Inc. and Subsidiaries
MATTER NO.: 1001-00004
CLIENT: Ardent Capital Partners III LP
Right-click to update Table of Contents
I. Executive Summary
This memorandum summarizes the findings of our review of the material contracts of Luminex Systems Holdings Inc. ("Luminex Holdings" or the "Company" or the "Target") and its subsidiaries (collectively, "Luminex") in connection with the proposed acquisition of Luminex Holdings by Ardent Capital Partners III LP ("Ardent Capital"). The acquisition is structured as a reverse triangular merger in which Ardent Apex Merger Sub Inc. ("Merger Sub"), a newly formed, wholly owned subsidiary of Ardent Apex Holdings Inc. (itself a wholly owned subsidiary of Ardent Capital), will merge with and into Luminex Holdings, with Luminex Holdings surviving as a wholly owned subsidiary of Ardent Apex Holdings Inc. The aggregate equity consideration is $2,800,000,000, reflecting a price of $20.00 per share on approximately 140,000,000 fully diluted shares. The transaction is governed by the Agreement and Plan of Merger dated March 24, 2025 (the "Merger Agreement").
The scope of this review encompasses all contracts provided by Luminex in the virtual data room maintained by Caldwell, Raines & Sheppard LLP ("CRS"), counsel to the Target and the selling stockholders (Patricia Okonkwo, lead partner; Daniel Feinberg, associate), in response to Calderwood & Harkness's comprehensive due diligence request list dated March 6, 2025, as supplemented on March 17, 2025 and March 31, 2025. Our review has covered customer agreements (both enterprise license agreements and standard commercial contracts), vendor and supplier agreements, technology partnership and reseller agreements, U.S. government contracts, intercompany agreements, existing credit facilities, and — on a summary cross-reference basis — real property leases, employment agreements, and insurance contracts, each of which is the subject of separate due diligence memoranda prepared by the respective Calderwood & Harkness practice groups.
Summary Finding. Approximately 340 commercial contracts and 26 enterprise license agreements ("ELAs") contain change of control provisions that require either affirmative consent or notice in connection with the merger. The reverse triangular merger structure — in which Merger Sub merges into Luminex Holdings, with Luminex Holdings as the surviving corporation — constitutes a "change of control" under substantially all of these agreements. The vast majority of the relevant contracts define "change of control" broadly to include any merger, consolidation, acquisition, or transfer of more than 50% of a party's voting interests or equity securities, and the fact that Luminex Holdings survives the merger does not avoid triggering these provisions because ultimate ownership of Luminex Holdings will change from its current public stockholders to Ardent Capital.
Key Areas of Concern. We have identified the following key areas of concern requiring immediate attention by the deal team:
(a) U.S. Government Contracts with DOD, DOE, and GSA. Luminex US (Luminex Systems Inc.) holds firm-fixed-price and IDIQ contracts with the Department of Defense, the Department of Energy, and the General Services Administration. These contracts implicate FAR 42.12 (Novation and Change-of-Name Agreements), the Anti-Assignment Act (41 U.S.C. § 6305), and the pending CFIUS voluntary joint notice (Tracking No. CFIUS-2025-0087) filed on April 4, 2025. Novation agreements and contracting officer notifications are in preparation.
(b) Top-Revenue Customer Agreements with Anti-Assignment and Change of Control Clauses. The 26 ELAs, representing the Company's largest and most strategically significant customer relationships, each contain change of control provisions that grant the customer either a consent right, a termination right, or both. Approximately 60% of ELA-attributable annual recurring revenue ("ARR") is concentrated in the top 10 customers, creating meaningful revenue-at-risk exposure if consents are not obtained.
(c) Key Vendor and Technology Partnership Agreements. Certain mission-critical vendor agreements — including the Company's principal cloud hosting arrangement and key inbound software licenses embedded in the Luminex One platform — contain anti-assignment or change of control provisions that could, if consent is not obtained, disrupt product delivery and platform operations.
(d) Intercompany IP Licensing Arrangements. The principal intercompany intellectual property license between Luminex Systems AG (the Swiss parent entity) and Luminex Systems Inc. (the U.S. operating subsidiary) provides for a royalty rate of 4.5% of U.S. net revenues. This rate is expected to be restructured to 6.0% of U.S. net revenues following closing, based on the transfer-pricing benchmark study conducted by Pendleton & Associates LLP (Richard Chow, engagement partner). The amendment will require coordination with local counsel in Switzerland and with Sylvia Hartwell regarding U.S. and Swiss tax implications.
(e) Credit Facility Change of Control Provisions. Luminex Holdings' existing indebtedness is subject to change of control mandatory prepayment and event of default provisions. All existing indebtedness is expected to be repaid in full at closing from transaction proceeds, with payoff letters and lien releases to be coordinated with existing lenders.
This memorandum should be read in conjunction with the Change of Control / Consent Tracker (internal working spreadsheet) maintained separately by Megan Chu and updated on a rolling basis, which tracks the status of consent solicitation and notice delivery for each affected contract. In addition, the Merger Agreement contains interim operating covenants (Article V, Sections 5.1(b)(iv), 5.1(b)(viii), and 5.1(b)(xii)) that restrict Luminex from, among other things, entering into new contract commitments with a value in excess of $2,000,000, licensing intellectual property outside the ordinary course of business, and making capital expenditures in excess of $5,000,000, in each case without the prior written consent of Ardent Capital. Our ongoing monitoring of Luminex's compliance with these covenants is discussed in Section VII below.
II. Scope and Methodology
A. Data Room Review
We conducted our review of Luminex's material contracts using the documents provided in the virtual data room hosted and maintained by CRS on the Thackeray Solutions platform (Project Name: "Apex"). The data room was first populated on March 10, 2025, and CRS has made supplemental uploads on a rolling basis, with the most recent upload occurring on April 10, 2025. As of the date of this memorandum, the data room contains approximately 4,200 documents organized into the following principal contract categories:
• Customer Agreements. Enterprise license agreements, standard SaaS subscription agreements, professional services agreements, and support and maintenance contracts.
• Vendor and Supplier Agreements. Cloud hosting and infrastructure agreements, third-party software licenses (inbound), consulting and professional services agreements, telecommunications contracts, and data center services agreements.
• Technology Partnership and Reseller Agreements. Technology partnership and integration agreements, co-selling and co-marketing arrangements, and channel distribution and reseller agreements.
• Government Contracts. U.S. federal government contracts (DOD, DOE, GSA), state and local government contracts, and related subcontract arrangements.
• Distribution and Reseller Agreements. Regional distribution agreements for DACH, North America, UK & Nordics, and APAC markets.
• Intercompany Agreements. intellectual property licensing agreements, shared services agreements, cost-sharing and cost-plus arrangements, and management services agreements among Luminex group entities.
• Real Property Leases. Office and facility leases for Luminex's global operations. These are the subject of a separate Real Property & Leases Due Diligence Summary Memorandum prepared by the Calderwood & Harkness real estate team, and are addressed in this memorandum only on a summary cross-reference basis (Section III.H below).
• Employment Agreements and Equity Incentive Plans. Executive employment agreements, change of control and severance arrangements, and equity incentive plan documents. These are the subject of a separate Employment & Benefits Due Diligence Summary Memorandum prepared by the Calderwood & Harkness employment and benefits team, and are addressed in this memorandum only on a summary cross-reference basis (Section III.I below).
Our review encompasses all contracts in the foregoing categories that were in force as of March 24, 2025, the execution date of the Merger Agreement. Contracts that expired or were terminated prior to that date have been excluded from our analysis, except where residual obligations (such as indemnification, confidentiality, or post-termination royalty obligations) remain in effect.
We note that the data room remains subject to ongoing supplemental population by CRS, and we have requested that CRS confirm that all material contracts within the categories specified in our due diligence request list have been provided. Patricia Okonkwo confirmed in an email dated April 8, 2025, that CRS believes the data room to be substantially complete with respect to the contract categories listed above, subject to a final completeness certification to be delivered by the Target at closing pursuant to Section 6.2(e) of the Merger Agreement.
B. Review Team
The material contracts review has been led by Ryan Kowalski (Lead Associate) and Megan Chu (Working Associate) of the Calderwood & Harkness M&A practice group. We have received substantive input and guidance from the following additional attorneys and advisors:
• Elaine Forsythe (Counsel, Calderwood & Harkness Government Contracts and Antitrust Group) — government contracts analysis, FAR/DFARS compliance, Anti-Assignment Act issues, CFIUS coordination, and HSR Act/FTC review coordination, including assessment of the Vectis Solutions LLC competitive overlap.
• Sylvia Hartwell (Senior Associate, Calderwood & Harkness Tax Group) — review of tax-related contract provisions, transfer pricing analysis for intercompany IP licensing arrangements, Section 338(h)(10) analysis coordination, and Swiss withholding tax issues.
• Dr. Lukas Breitfeld and team, Breitfeld Hess & Partner AG (Zürich, Switzerland) — local counsel review of Swiss-governed contracts, including the intercompany IP license between Luminex Systems AG and Luminex Systems Inc., and Swiss regulatory requirements applicable to assignment and change of control provisions under Swiss law.
• Dr. Katarina Wendt and team, Wendt Schäfer Rechtsanwälte PartG mbB (Munich, Germany) — local counsel review of German-governed contracts, including customer and vendor agreements entered into by Luminex Systems GmbH.
• Kelvin Tan and team, Tan Liang & Associates LLP (Singapore) — local counsel review of Singapore-governed contracts entered into by Luminex Systems Pte. Ltd.
C. Materiality Thresholds
In consultation with James Prentice and Sandra Tung, we applied the following materiality thresholds to determine which contracts warranted full substantive review:
1. All contracts with an annual value exceeding $1,000,000 (including, for SaaS subscription agreements, the annual contract value or "ACV," and for multi-year agreements, the annualized value of total contract consideration).
2. All contracts with government entities, regardless of value. Given the CFIUS filing and the sensitivity of Luminex's government business, no dollar threshold was applied to government contracts.
3. All contracts containing change of control, anti-assignment, or consent-to-assign provisions, regardless of value. Our initial screen for such provisions was conducted through a combination of keyword searches across the data room and review of Luminex management's internally maintained contract database.
4. All intercompany agreements among Luminex group entities, regardless of value, given the transfer-pricing restructuring and post-closing integration considerations.
5. All contracts involving intellectual property licensing, whether inbound (licenses granted to Luminex by third parties) or outbound (licenses granted by Luminex to customers or partners), regardless of value.
Contracts falling below all five of the above thresholds were excluded from full substantive review but were catalogued in the Change of Control / Consent Tracker for completeness. We estimate that approximately 85% of all contracts in the data room received full substantive review under the above criteria.
D. Classification Framework
For purposes of this memorandum and the Change of Control / Consent Tracker, we have classified each reviewed contract into one of the following five categories:
Category 1 — Affirmative Consent Required Prior to Closing. Contracts that require the prior written consent of the counterparty before the merger may be consummated or before a change of control may occur, and where the absence of such consent would constitute a breach, default, or termination event under the contract.
Category 2 — Notice Only (No Consent Required). Contracts that require Luminex to provide written notice to the counterparty of the change of control or assignment, but that do not condition the effectiveness of the transaction on the counterparty's consent or approval.
Category 3 — Counterparty Termination Right Triggered Upon Change of Control. Contracts where the change of control does not require prior consent but grants the counterparty a right to terminate the agreement (typically upon 30–90 days' written notice) following the occurrence of the change of control. In many cases, these termination rights are accompanied by an obligation to provide a pro-rata refund of prepaid fees.
Category 4 — Pricing Renegotiation or Adjustment Provisions Triggered Upon Change of Control. Contracts where the change of control triggers a right of either party (typically the customer) to request renegotiation of pricing, service levels, or other commercial terms. These contracts do not grant a termination right but create potential economic exposure through pricing adjustments.
Category 5 — No Change of Control, Assignment, or Consent Provisions / Merger Carve-Out. Contracts that either contain no change of control or anti-assignment provisions, or that contain an express carve-out permitting assignment or change of control in connection with a merger, acquisition, or sale of all or substantially all assets. These contracts do not require any affirmative action prior to closing, although we recommend that courtesy notice be provided as a matter of good commercial practice.
We note that many contracts contain overlapping provisions — for example, a contract may require both prior consent (Category 1) and grant a termination right if consent is not obtained or if the change of control occurs without consent (Category 3). In such cases, we have classified the contract based on the most restrictive applicable provision. All overlapping categorizations are noted in the Change of Control / Consent Tracker.
III. Summary of Material Contract Categories
A. Customer Agreements — Enterprise License Agreements (ELAs)
1. Overview. Luminex operates its proprietary "Luminex One" platform, a cloud-based enterprise resource planning, procurement automation, and supply-chain analytics software-as-a-service ("SaaS") offering. The Luminex One platform is marketed primarily to large enterprise and government customers under multi-year enterprise license agreements that combine platform subscription fees, implementation and professional services fees, and ongoing support and maintenance charges.
Our review has identified 26 enterprise license agreements that contain change of control provisions requiring either consent, notice, or both, in connection with the merger. These 26 ELAs represent Luminex's largest and most strategically significant customer relationships. Together, these agreements account for a substantial majority of Luminex's consolidated revenue.
For the fiscal year ended December 31, 2024, Luminex reported the following revenue metrics:
Geographic breakdown of 2024 total revenue is as follows:
The 26 ELAs with change of control provisions are predominantly multi-year subscription agreements with initial terms ranging from three to five years, many of which include one or more automatic renewal periods. The ELAs are governed by a combination of Luminex's standard enterprise license terms and individually negotiated addenda reflecting customer-specific requirements regarding data security, service levels, audit rights, and — critically for our purposes — assignment, change of control, and consent provisions.
2. Key ELA Terms and Change of Control Provisions
The standard Luminex ELA form includes a provision captioned "Assignment and Change of Control" (typically appearing in Article 12 or Article 14 of the ELA, depending on the form version). The standard provision reads as follows:
"Neither party may assign, transfer, or delegate this Agreement or any of its rights or obligations hereunder without the prior written consent of the other party, which consent shall not be unreasonably withheld, conditioned, or delayed; provided, however, that either party may assign this Agreement without consent to an affiliate or in connection with a merger, acquisition, or sale of all or substantially all of its assets, provided that the assignee agrees in writing to be bound by the terms and conditions of this Agreement. For purposes of this Agreement, a 'Change of Control' shall mean any merger, consolidation, acquisition, reorganization, or sale or transfer of more than 50% of the voting interests or equity securities of a party. Upon the occurrence of a Change of Control, the affected party shall provide written notice to the other party within thirty (30) days of the effective date of the Change of Control."
Under the standard form, the reverse triangular merger would generally fall within the "merger, acquisition, or sale of all or substantially all assets" carve-out, and consent would not be required — only notice. However, 24 of the 26 ELAs contain negotiated modifications to this standard provision that either (a) delete the merger/acquisition carve-out entirely, (b) add an express requirement that the customer provide affirmative consent prior to any change of control, or (c) grant the customer a right to terminate the agreement upon the occurrence of a change of control, typically upon 30 to 90 days' written notice and with a pro-rata refund of prepaid subscription fees. Two of the 26 ELAs retain the standard carve-out language but define "change of control" in a manner that captures indirect changes in beneficial ownership, thereby still requiring notice and potentially consent.
The reverse triangular merger constitutes a "change of control" under each of the 26 ELAs. Although Luminex Holdings survives the merger and remains the contracting entity (or the parent of the contracting subsidiary entity), the ultimate beneficial ownership of Luminex Holdings will change from its current public stockholders to Ardent Capital. This change is captured by the broad change of control definitions in each ELA.
The typical remedies available to the customer upon an unconsented change of control include:
• A right to terminate the ELA upon 30 to 90 days' written notice to Luminex;
• A right to receive a pro-rata refund of any prepaid and unearned subscription fees;
• In certain ELAs, a right to request renegotiation of pricing, service levels, or other material commercial terms; and
• In certain ELAs, a right to obtain a copy of the source code from the escrow agent under the applicable software escrow agreement.
3. Top Customer ELAs Requiring Consent (Representative Examples)
Set forth below are summaries of the most material ELAs by revenue contribution. These seven ELAs collectively represent approximately $164,800,000 in annual contract value, or approximately 37.4% of total 2024 ARR. Approximately 60% of total ELA revenue is concentrated in the top 10 customers.
a. Rheinhardt Industrial Group AG
• Luminex Entity: Luminex Systems GmbH
• Contract Date: September 15, 2021 (amended January 8, 2024)
• Annual Contract Value: $38,200,000
• Remaining Term: Initial term expires September 14, 2026; one two-year automatic renewal period
• Change of Control Clause: Section 14.2 — "Notwithstanding Section 14.1, in the event of a Change of Control (as defined herein) of Licensor or Licensor's parent company, Licensee shall have the right, exercisable by written notice delivered within sixty (60) days of receiving notice of such Change of Control, to (i) terminate this Agreement effective ninety (90) days following delivery of such notice, and receive a pro-rata refund of all prepaid fees attributable to the period following the effective date of termination, or (ii) request renegotiation of pricing and service level commitments for the remaining term of this Agreement."
• Category: Category 1 / Category 3 (consent required; customer termination right)
• Status of Consent Outreach: Preliminary discussions initiated by Target management (Dr. Stefan Kessler) with Rheinhardt's CIO, Friedrich Neumann, on April 2, 2025. No formal consent letter has been delivered. Rheinhardt has expressed willingness to continue the relationship but has indicated a desire to negotiate enhanced data residency protections in connection with any consent.
• Risk Assessment: HIGH. Rheinhardt is Luminex's single largest customer. Termination of this ELA would result in a loss of approximately 8.7% of total ARR. Moreover, Rheinhardt's departure could signal market concern to other DACH-region customers.
b. TransAtlantic Logistics Corporation
• Luminex Entity: Luminex Systems Inc.
• Contract Date: March 1, 2022 (amended July 15, 2023)
• Annual Contract Value: $31,500,000
• Remaining Term: Initial term expires February 28, 2027; two one-year automatic renewal periods
• Change of Control Clause: Section 12.3 — "This Agreement may not be assigned by either party, in whole or in part, without the prior written consent of the other party. For the avoidance of doubt, a Change of Control of either party shall constitute an assignment requiring consent under this Section 12.3. 'Change of Control' means any direct or indirect change in the ownership or control of more than fifty percent (50%) of the voting securities or equity interests of a party, whether by merger, consolidation, sale, transfer, or otherwise."
• Category: Category 1 (affirmative consent required)
• Status of Consent Outreach: No outreach initiated. Target management has indicated that the relationship with TransAtlantic is managed by Luminex's Head of North America Sales, David Okafor, who has recommended a coordinated outreach with the Ardent Capital operating team.
• Risk Assessment: HIGH. TransAtlantic is Luminex's second-largest customer and the largest North American customer. The contract contains no merger carve-out and explicitly treats a change of control as an assignment requiring consent.
c. Nordstern Energie GmbH & Co. KG
• Luminex Entity: Luminex Systems GmbH
• Contract Date: June 1, 2020 (second renewal effective June 1, 2023)
• Annual Contract Value: $27,400,000
• Remaining Term: Current renewal term expires May 31, 2026; one additional two-year renewal period remaining
• Change of Control Clause: Section 15.1(b) — "In the event of a Change of Control of Licensor, Licensee shall have the right to terminate this Agreement upon not less than thirty (30) days' prior written notice, with a pro-rata refund of prepaid fees. Licensee shall also have the right to require Licensor to provide Licensee with a complete copy of all source code for the Licensed Software held in escrow under the Escrow Agreement."
• Category: Category 3 (customer termination right)
• Status of Consent Outreach: CRS (Daniel Feinberg) has been asked to coordinate with Luminex Systems GmbH's managing director, Andreas Mayer, to initiate outreach. No formal notice or consent request has been delivered.
• Risk Assessment: HIGH. Nordstern is a top-3 customer. The termination right is triggered automatically upon the change of control, with only a 30-day notice period, creating a short window for engagement.
d. Meridian Health Systems plc
• Luminex Entity: Luminex Systems UK Ltd.
• Contract Date: November 1, 2022
• Annual Contract Value: $22,800,000
• Remaining Term: Initial term expires October 31, 2027; no automatic renewal
• Change of Control Clause: Section 11.4 — "Neither party may assign this Agreement without the prior written consent of the other party. Any Change of Control of a party shall require the prior written consent of the other party, not to be unreasonably withheld, conditioned, or delayed. In the event that consent is not obtained prior to the effective date of the Change of Control, the non-assigning party shall have the right to terminate this Agreement upon sixty (60) days' notice."
• Category: Category 1 / Category 3
• Status of Consent Outreach: No outreach initiated. Luminex Systems UK Ltd. managing director, Sophie Cartwright, has been briefed on the transaction by Dr. Kessler and has indicated that Meridian Health's procurement team will require formal written notice.
• Risk Assessment: MEDIUM-HIGH. Consent is subject to a "not unreasonably withheld" standard, which provides some comfort, but the 60-day termination right remains available if consent is not obtained prior to closing.
e. Pacific Basin Shipping Ltd.
• Luminex Entity: Luminex Systems Pte. Ltd.
• Contract Date: February 15, 2023
• Annual Contract Value: $18,900,000
• Remaining Term: Initial term expires February 14, 2028; one two-year automatic renewal
• Change of Control Clause: Section 13.2 — Change of control defined as any change in "ultimate beneficial ownership or control" of a party; consent required prior to change of control; no reasonableness standard; customer may terminate immediately if consent not obtained.
• Category: Category 1 / Category 3
• Status of Consent Outreach: Kelvin Tan (Tan Liang & Associates LLP) has been engaged to coordinate outreach under Singapore law requirements.
• Risk Assessment: MEDIUM-HIGH. The absence of a reasonableness standard on the consent requirement and the immediate termination right create heightened risk.
f. Bundesamt für Beschaffung (Swiss Federal Office of Procurement)
• Luminex Entity: Luminex Systems AG
• Contract Date: April 1, 2021 (renewed April 1, 2024)
• Annual Contract Value: CHF 14,200,000 (approximately $16,200,000 at current exchange rates)
• Remaining Term: Renewal term expires March 31, 2027
• Change of Control Clause: Standard Swiss federal procurement terms; change of control requires notification to contracting authority; contracting authority retains right to terminate for cause if change of control materially affects contractor's ability to perform
• Category: Category 2 / Category 3
• Status of Consent Outreach: Breitfeld Hess & Partner AG (Dr. Lukas Breitfeld) is preparing the required notification under Swiss public procurement law.
• Risk Assessment: MEDIUM. Swiss federal procurement regulations impose specific notification obligations. The termination right is limited to circumstances where the change of control materially affects performance capability, which we do not anticipate would be applicable here given the continuity of personnel and operations.
g. GlobalTech Manufacturing Inc.
• Luminex Entity: Luminex Systems Inc.
• Contract Date: August 1, 2023
• Annual Contract Value: $9,800,000
• Remaining Term: Initial term expires July 31, 2026; two one-year automatic renewals
• Change of Control Clause: Section 14.1 — Assignment requires prior written consent; change of control treated as assignment; no merger carve-out. Section 14.2 — Upon change of control, customer may renegotiate pricing for the remaining term or terminate upon 90 days' notice.
• Category: Category 1 / Category 4
• Status of Consent Outreach: Preliminary internal discussions at Luminex. No formal outreach.
• Risk Assessment: MEDIUM. The pricing renegotiation right is of particular concern given that GlobalTech negotiated significant volume-based discounts in the original ELA, and a change of control renegotiation could result in pressure to further reduce pricing.
4. Recommendations. Based on our review of the ELAs, we make the following recommendations:
(a) Prioritize consent solicitation for the top 10 revenue ELAs immediately. The seven ELAs summarized above, together with three additional ELAs with annual contract values ranging from $7,500,000 to $9,200,000, represent the most material revenue exposure. Consent outreach for these customers should be initiated no later than April 21, 2025, to allow adequate time for negotiation and execution of consent letters prior to the anticipated closing date.
(b) Prepare form consent letters for distribution. We have prepared a draft form consent letter for review by the deal team. The form letter should be finalized and distributed to CRS (Daniel Feinberg) for coordination with Target management on customer-facing communications. Given the sensitivity of customer relationships, we recommend that initial outreach be led by Target management (Dr. Kessler and the relevant regional sales leaders), with Calderwood & Harkness and CRS providing support as needed.
(c) Monitor against Merger Agreement covenants. The interim operating covenants in Section 5.1(b)(iv) of the Merger Agreement restrict Luminex from entering into new contract commitments with a value in excess of $2,000,000 without Ardent Capital's prior written consent. We should monitor whether any ELA amendments, extensions, or renewals undertaken in connection with the consent solicitation process could implicate these covenants. Similarly, Section 5.1(b)(viii) restricts IP licensing outside the ordinary course of business.
(d) Assess the need for closing conditions related to key consents. Under Section 7.2(c) of the Merger Agreement, the receipt of specified third-party consents may be a condition precedent to Ardent Capital's obligation to close. We should confirm with James Prentice and Sandra Tung which, if any, of the ELA consents should be designated as required closing conditions, taking into account the revenue-at-risk analysis set forth in Section IV below.
B. Customer Agreements — Standard Commercial Contracts
1. Overview. In addition to the 26 ELAs described above, our review has identified approximately 314 additional commercial contracts containing change of control or anti-assignment provisions. These contracts are standard SaaS subscription agreements, professional services agreements, and support and maintenance contracts entered into on Luminex's standard terms with smaller enterprise customers and mid-market accounts. Together with the 26 ELAs, approximately 340 commercial contracts contain provisions relevant to the merger.
The vast majority of the 314 standard commercial contracts use Luminex's standard form terms and conditions, which include the anti-assignment clause quoted in Section III.A.2 above. However, many customers have negotiated deviations from the standard form, resulting in varied treatment of assignment and change of control across the contract portfolio.
2. Change of Control / Anti-Assignment Analysis
Our analysis of the 314 standard commercial contracts reveals the following breakdown:
Contracts with Standard Merger/Acquisition Carve-Out (Approximately 210 Contracts). Approximately 210 contracts use the standard Luminex form with the merger/acquisition carve-out substantially in the form quoted in Section III.A.2 above. Under this carve-out, either party may assign the agreement without the other party's consent "in connection with a merger, acquisition, or sale of all or substantially all of its assets, provided that the assignee agrees in writing to be bound by the terms and conditions of this Agreement." Because the reverse triangular merger falls within this carve-out, and because Luminex Holdings (the surviving entity) will be bound by all pre-merger obligations, these contracts do not require separate consent for the merger. We have classified these contracts as Category 5 (no consent required) or, in some instances, Category 2 (notice recommended as good commercial practice, even though not contractually required).
Contracts with Negotiated Deviations (Approximately 130 Contracts). Approximately 130 contracts contain negotiated modifications to the standard form that create consent or notice obligations in connection with the merger. The most common deviations include:
(i) Deletion of the merger/acquisition carve-out, resulting in a blanket prohibition on assignment without consent;
(ii) Addition of an express "change of control" definition and consent requirement separate from the anti-assignment clause;
(iii) Addition of a customer termination right triggered upon a change of control;
(iv) Addition of a pricing renegotiation or "most favored nation" adjustment clause triggered upon a change of control; and
(v) Addition of a requirement that the non-assigning party receive written notice of the change of control within a specified period (typically 30 days) following the effective date.
These 130 contracts, combined with the 26 ELAs described in Section III.A, bring the total number of contracts requiring affirmative action (consent, notice, or both) to approximately 156 contracts.
3. Recommendations.
(a) Track all 340 contracts (26 ELAs + 314 standard commercial contracts) in the Change of Control / Consent Tracker, with appropriate categorization by consent/notice requirements.
(b) Prioritize the approximately 156 contracts requiring affirmative consent or notice, focusing first on the ELAs (as described in Section III.A above) and then on the standard commercial contracts with the highest annual contract values.
(c) For the approximately 210 standard-form contracts with the merger/acquisition carve-out, prepare and send courtesy notice letters post-signing but prior to closing. While not contractually required, such notices serve to maintain customer goodwill and reduce the risk of post-closing disputes regarding the applicability of the carve-out.
(d) For contracts with negotiated deviations that contain ambiguous change of control or assignment language, consult with Megan Chu for contract-specific analysis and, where appropriate, seek confirmation from CRS as to the counterparty's interpretation.
C. U.S. Government Contracts
1. Overview. Luminex US (Luminex Systems Inc., a Delaware corporation with principal offices at 2100 Reston Gateway Drive, Suite 800, Reston, Virginia 20191; EIN: 86-2547210) is the primary U.S. operating subsidiary of Luminex Holdings. Luminex US employs approximately 1,650 individuals in the United States and generated 2024 U.S. revenue of $194,800,000. Luminex US holds contracts with three U.S. federal agencies — the Department of Defense (DOD), the Department of Energy (DOE), and the General Services Administration (GSA) — as well as a limited number of state and local government contracts.
The government contracts are of heightened significance in the context of this transaction for two reasons. First, they implicate specific federal procurement regulations governing assignment, novation, and change of control of government contractors. Second, they are central to the CFIUS voluntary joint notice (Tracking No. CFIUS-2025-0087) filed jointly by Ardent Capital and Luminex Holdings on April 4, 2025, reflecting the assessment of the transaction team that the merger constitutes a "covered transaction" under 31 C.F.R. Part 800 due to Luminex's access to government systems, sensitive procurement data, and classified logistics information in connection with the DOD contract.
2. Department of Defense (DOD) — Logistics Software Module
Contract Type: Firm-fixed-price task order issued under the Alliant 2 Government-Wide Acquisition Contract (GWAC), administered by the General Services Administration.
Description: Luminex One logistics and supply-chain analytics module deployed for DOD logistics operations, including inventory management, distribution planning, and maintenance scheduling for non-classified logistics programs. Luminex US provides both the SaaS platform and associated implementation, training, and ongoing support services.
Approximate Annual Value: $34,600,000 (combining platform subscription fees and professional services under the current task order period of performance).
Period of Performance: Current task order period of performance expires September 30, 2026, with two one-year option periods remaining.
FAR/DFARS Provisions: The contract incorporates the following provisions relevant to the change of control analysis:
• FAR 42.12 — Novation and Change-of-Name Agreements. FAR 42.1204 sets forth the conditions under which the government will recognize a successor in interest to a government contract. The contracting officer may execute a novation agreement recognizing the transferee as the successor contractor. The novation process requires the submission of documentation establishing the legal transfer of the contract, including certified copies of the merger documents, an opinion of counsel regarding the validity of the transfer, and evidence of the successor's capability to perform.
• FAR 52.242-14 — Suspension of Work. Standard clause permitting the contracting officer to suspend work pending resolution of issues related to the contract, including issues arising from a change in contractor ownership.
• DFARS 252.204-7012 — Safeguarding Covered Defense Information and Cyber Incident Reporting. This clause imposes cybersecurity requirements on the contractor, including NIST SP 800-171 compliance, that will need to be maintained by the successor entity.
• DFARS 252.239-7010 — Cloud Computing Services. Imposes FedRAMP authorization and DOD Cloud Security requirements applicable to the Luminex One platform deployment.
Change of Control Analysis: The reverse triangular merger results in a change of control of the ultimate parent entity of Luminex US. Although Luminex US itself remains intact as a legal entity (it is a subsidiary of Luminex Holdings, the surviving corporation), the ownership of Luminex Holdings will change from its current public stockholders to Ardent Capital. This change in ultimate ownership triggers the novation and notification requirements under FAR 42.12.
Anti-Assignment Act (41 U.S.C. § 6305): The Anti-Assignment Act generally prohibits the transfer or assignment of government contracts without government approval. However, the recognized successor exception applies in situations where a contractor entity continues in existence following a stock acquisition or merger that changes the ownership of the contractor but does not result in the transfer of the contract to a different legal entity. In a reverse triangular merger where the target (Luminex Holdings) is the surviving corporation and the contracting subsidiary (Luminex US) remains intact, the recognized successor exception should apply, though formal notification to the contracting officer remains required.
CFIUS Overlay: The DOD contract has been identified as a primary basis for the CFIUS filing. Although Ardent Capital is a U.S.-domiciled fund, the CFIUS analysis reflects certain non-U.S. limited partner interests in Ardent Capital Partners III LP. The CFIUS team (Elaine Forsythe, coordinating with outside CFIUS counsel at Whitmore & Bishop LLP) is managing the CFIUS review process. Potential mitigation measures under discussion include a proxy board arrangement for Luminex US, a cleared-facility compliance undertaking, and government-contract carve-outs ensuring continued government oversight.
Status: Pre-closing notification to the contracting officer is in preparation. Elaine Forsythe is coordinating with the DOD contracting officer's representative to schedule an initial briefing. We anticipate that the novation process will require 60 to 90 days from initial submission, and we are evaluating whether novation can be completed prior to the anticipated closing date or whether post-closing completion will be acceptable under the Merger Agreement.
3. Department of Energy (DOE) — Procurement Platform
Contract Type: Indefinite delivery/indefinite quantity (IDIQ) contract.
Description: Luminex One procurement automation module deployed at DOE facilities for the management of procurement workflows, vendor management, and contract administration. The platform processes procurement requests, automates approval workflows, and provides analytics on procurement spend across multiple DOE sites.
Approximate Annual Value: $18,200,000 (based on 2024 task order volume under the IDIQ contract).
Period of Performance: Base IDIQ ordering period expires March 31, 2027; individual task orders have varying periods of performance.
FAR Novation/Change-of-Name Requirements: The same FAR 42.12 novation requirements apply to this contract as to the DOD contract described above. The contracting officer must be notified of the change in ultimate ownership, and a novation agreement may be required.
CFIUS Basis: The DOE contract has been flagged as involving sensitive technology procurement, given that the Luminex One platform processes and stores procurement data related to DOE facilities and programs. This has been identified as a secondary basis for the CFIUS filing.
Status: Notification to the DOE contracting officer is in preparation. Elaine Forsythe is coordinating with DOE procurement counsel.
4. General Services Administration (GSA) — Enterprise License
Contract Type: GSA Schedule / Multiple Award Schedule (MAS) contract, formerly known as a Federal Supply Schedule (FSS) contract.
Description: Luminex One enterprise license available for ordering by federal civilian agencies through the GSA Advantage! online procurement portal. The GSA Schedule contract establishes pre-negotiated pricing, terms, and conditions under which federal agencies may place orders for Luminex One subscriptions and related services.
Approximate Annual Value: $8,400,000 (based on 2024 orders placed through the GSA Schedule).
Period of Performance: Current five-year option period expires June 30, 2026; one additional five-year option period available.
GSA Schedule Assignment/Novation Provisions: GSA Schedule contracts include standard assignment and novation provisions under GSA Order ADM 4800.2H and the applicable GSA Schedule terms and conditions. A change in ultimate ownership of the contractor requires notice to the GSA contracting officer and, in most cases, execution of a novation agreement. GSA has established streamlined procedures for processing novation requests in connection with mergers and acquisitions.
Status: Notification to the GSA contracting officer is in preparation. We anticipate that the GSA novation process will be relatively straightforward given the streamlined procedures available for stock acquisitions and reverse mergers where the contracting entity remains intact.
5. State and Local Government Contracts
Our review of the data room has identified four state government contracts and two local government contracts held by Luminex US:
• Commonwealth of Virginia — Department of General Services (procurement automation; ACV: $2,100,000)
• State of California — Department of Technology (supply chain analytics; ACV: $3,400,000)
• State of Texas — Department of Information Resources (ERP module; ACV: $1,800,000)
• State of New York — Office of General Services (procurement automation; ACV: $2,700,000)
• Fairfax County, Virginia (procurement automation; ACV: $620,000)